Inflammation and Pharmacological Treatment in Diabetic Retinopathy
Diabetic retinopathy (DR), the most common microvascular complication of diabetes mellitus, is estimated to be the leading cause of new blindness in the working population of developed countries. Primary interventions such as intensive glycemic control, strict blood pressure regulation, and lipid-mo...
Saved in:
Main Authors: | Snježana Kaštelan (Author), Martina Tomić (Author), Antonela Gverović Antunica (Author), Jasminka Salopek Rabatić (Author), Spomenka Ljubić (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2013-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Body Mass Index: A Risk Factor for Retinopathy in Type 2 Diabetic Patients
by: Snježana Kaštelan, et al.
Published: (2013) -
Inflammation, Haemostatic Disturbance, and Obesity: Possible Link to Pathogenesis of Diabetic Retinopathy in Type 2 Diabetes
by: Martina Tomić, et al.
Published: (2013) -
Epidemiolgy of Rhegmatogenous Retinal Detachment in Dubrovnik-Neretva County
by: Ivana Carevic, et al.
Published: (2018) -
Maternal immune system adaptation to pregnancy - a potential influence on the course of diabetic retinopathy
by: Pavan Josip, et al.
Published: (2010) -
The potential effects and mechanisms of hispidulin in the treatment of diabetic retinopathy based on network pharmacology
by: Yao Chen, et al.
Published: (2022)